1,852
Views
4
CrossRef citations to date
0
Altmetric
Clinical focus: Neurological and Psychiatric Disorders - Editorial

Interventional psychiatry

, , , , &
Pages 573-574 | Received 17 Aug 2019, Accepted 06 Feb 2020, Published online: 13 Feb 2020
 

Declaration of interest

None of the authors have any relevant conflicts of interest to report. Dr. El-Mallakh has received research funding from Janssen and Sage, and is a speaker for Allergan, Janssen, Lundbeck, Neurocrine, Otsuka, Takeda, and Teva. The other authors have no conflicts of interest.

The contents of the paper and the opinions expressed within are those of the authors, and it was the decision of the authors to submit the manuscript for publication.

Reviewers disclosure

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This work was not supported by extramural funding.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.